The increasing morbidity and mortality of life-threatening Pneumocystis pneumonia (PCP) in
immunocompromised people poses a global concern, prompting the World Health …

Filamentous fungi have always been a matter of concern in the medical field, but nowadays,
due to an increase in the risk factors and the added infections with the SARS-CoV-2 virus …

The growing number of long COVID cases has drawn clinical attention to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been spreading worldwide …

The COVID-19 pandemic is raising a worldwide search for compounds that could act against
the disease, mainly due to its mortality. With this objective, many researchers invested in the …

Introduction During the COVID-19 Delta variant surge, the CLAIRE cross-sectional study
sampled saliva from 120 hospitalized patients, 116 of whom had a positive COVID-19 PCR …

Fungal infections have become clinically challenging owing to the emergence of drug
resistance in invasive fungi and the rapid increase in the number of novel pathogens. The …

Due to fungal diseases that threaten immunocompromised patients, along with the limited
availability of antifungal agents, there is an urgent need for new antifungal compounds to …

Background Pneumocystis jirovecii pneumonia (PCP) and SARS-CoV2 share some
similarities in their effects on the respiratory system, clinical presentation, and management …

A coccidioidomicose é uma micose profunda causada por fungos dimórficos do gênero
Coccidioides. As manifestações clínicas da infecção por Coccidioides spp. podem ser …

Introduction. Data on the prevalence of fungal coinfections/superinfections in patients with
COVID-19 are limited. Objective. To describe the prevalence of fungal coinfections …